AXLA Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 des 2023 @ 21:59):

Stats
Dagens volum	6 782.00
Gjennomsnittsvolum	54 521.00
Markedsverdi	1.18M
EPS	$0 ( 2024-03-28 )
Neste inntjeningsdato	( $0 ) 2024-05-02
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0220
ATR14	$0.625 (155.90%)

Insider Trading

Date	Person	Action	Amount	type
2023-03-01	Koziel Margaret	Sell	679	Common Stock
2023-02-17	Koziel Margaret	Buy	70 000	Stock Option (Right to Buy)
2023-02-17	Hinshaw William	Buy	275 000	Stock Option (Right to Buy)
2023-02-17	Fehlner Paul	Buy	70 000	Stock Option (Right to Buy)
2023-02-10	Fehlner Paul	Buy	5 221	Common Stock

INSIDER POWER
99.86
Last 92 transactions
Buy: 44 458 855 \| Sell: 477 523

Volum Korrelasjon

Lang: 0.47 (neutral)

Kort: 0.41 (neutral)

Signal:(20.847) Neutral

Axcella Health Inc Korrelasjon

10 Mest positive korrelasjoner
SEED	0.947
DZSI	0.941
POTX	0.94
INO	0.937
VIVE	0.933
RKDA	0.927
CHB	0.926
KRKR	0.926
PRPO	0.925
AQB	0.925

10 Mest negative korrelasjoner
MPRA	-0.943
NCAC	-0.941
APXI	-0.936
VMGA	-0.93
SCRM	-0.927
ALSA	-0.927
ZING	-0.926
TRON	-0.926
ARTEU	-0.924
ADAL	-0.921

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Axcella Health Inc Korrelasjon - Valuta/Råvare

-0.64
( weak negative )

-0.47
( neutral )

0.53
( weak )

-0.30
( neutral )

0.43
( neutral )

Axcella Health Inc Økonomi

Annual	2022
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-1.520

FY	2022
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-1.520

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-1.700

FY	2020
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-1.780

Financial Reports:

No articles found.

Axcella Health Inc

Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence; and AXA1125 that is in Phase 2b clinical trial for treating non-alcoholic steatohepatitis, as well as in Phase 2a clinical trial for Long COVID therapy for patients. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.

Sanntidsoppdatering for Axcella Health Inc [AXLA]

Upcoming Earnings Alert